Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$10B
P/E ratio
~14×
Div yield
0%
Revenue
~$13.7B
Patients
~296k
Clinics
~3,260
Rev. growth
+4%
Berkshire stake
~45%
In plain English
DaVita runs the largest network of kidney-dialysis clinics in the US, treating roughly 296,000 people with failing kidneys three times a week across more than 3,200 centres. It buys its machines and drugs from a handful of suppliers (Fresenius, Baxter, Amgen), bills mostly Medicare for the volume but earns nearly all its profit from a thin slice of commercially-insured patients — and is itself ~45%-owned by Warren Buffett's Berkshire Hathaway.
In simple terms
What DaVita really sells
DaVita runs the largest network of kidney-dialysis clinics in the US, treating roughly 296,000 people with failing kidneys three times a week across more than 3,200 centres. It buys its machines and drugs from a handful of suppliers (Fresenius, Baxter, Amgen), bills mostly Medicare for the volume but earns nearly all its profit from a thin slice of commercially-insured patients — and is itself ~45%-owned by Warren Buffett's Berkshire Hathaway.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.